[1]
2013. PREVALENCE, CAUSE, AND PRESCRIPTION TREND IN PATIENTS WITH UPPER RESPIRATORY TRACT INFECTIONS AND MEMBRANOUS TONSILLITIS. International Research Journal of Pharmacy. 4, 2 (Feb. 2013), 175–180. DOI:https://doi.org/10.56802/g7sd6f49.